Dr. Zalupski on Implications of the KEYNOTE-061 Trial in Gastric Cancer
What are the takeaways from recent mixed trial results for Keytruda in gastric cancer? Dr. Mark Zalupski of University of Michigan weighs... Read More
For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE